All Q2 FY27 results →

MT

MTAR Technologies Ltd

Q2 FY27

MTAR Technologies Q2 Results 2026 (FY27) investor presentation: Revenue & Margins

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Price₹7,159

Market cap₹22.0K Cr

P/E160.4

Updated30 Oct 2026

Read4 min read

MTAR Technologies Ltd Q2 FY27 key numbers

Revenue: Q2 FY27 EBITDA: Rs. 99.2 Cr, up 483.3% YoY.

As stated in MTAR Technologies Ltd's Q2 FY27 investor presentation · published 30 Oct 2026. Reported figures, not investment advice.

Based on MTAR Technologies Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Q2 FY27 Revenue from Operations: Rs. EBITDA for Q2 FY27: Rs.

From MTAR Technologies Ltd's Q2 FY27 earnings-call transcript · updated 30 Oct 2026.

Revenue & Sales Performance

Q2 FY27 Revenue from Operations: Rs. 406.8 Cr, up 200.0% YoY from Rs. 135.6 Cr in Q2 FY26 (Page 12)
H1 FY27 Revenue from Operations: Rs. 767.5 Cr, up 162.7% YoY from Rs. 292.2 Cr in H1 FY26 (Page 12)
Q2 FY27 EBITDA: Rs. 99.2 Cr, up 483.3% YoY (Page 12)
Q2 FY27 PAT: Rs. 59.8 Cr, up 1309.5% YoY (Page 12)
Revenue growth guided for current fiscal year (FY27) at 80% (Page 4)

2 more points from MTAR Technologies Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

EBITDA for Q2 FY27: Rs. 99.2 Cr, up 483.3% YoY (from Rs. 17.0 Cr in Q2 FY26)
EBITDA margin for Q2 FY27: 24.4% (compared to 12.5% in Q2 FY26)
Profit after Tax (PAT) for Q2 FY27: Rs. 59.8 Cr, up 1309.5% YoY (from Rs. 4.2 Cr in Q2 FY26)
PAT margin for Q2 FY27: 14.7% (up from 3.1% in Q2 FY26)

2 more points from MTAR Technologies Ltd's call on margins

Create a free account to keep reading this call

See what MTAR Technologies Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Data Centre Infrastructure Solutions Facility
Leased manufacturing facility, infrastructure being established
First article orders to be executed within next 6 months (from Oct 2026)
Designed for significant ramp-up in production volumes (Page 24)
Greenfield Facility for Oil & Gas and Clean Energy (Fuel Cells Phase 2 Expansion)
To cater to Weatherford and others
Expected commissioning by end Nov 2026 (Page 23)
New Facility for Phase 3 Expansion of Clean Energy – Fuel Cells
Capacity augmentation expected by March 2027
Focus on skilled manpower onboarding and automation for operational efficiency (Page 23)
Historical Capex Evidence

2 more points from MTAR Technologies Ltd's call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

The presentation shows an increase in borrowings from Rs. 221.6 Cr (Mar-26) to Rs. 318.5 Cr (Sep-26) in current borrowings, and a slight increase in non-current borrowings from Rs. 147.7 Cr to Rs. 147.8 Cr (Page 13 & 29).
Lease liabilities increased from Rs. 6.7 Cr (Mar-26) to Rs. 8.0 Cr (Sep-26) (Page 13 & 29).
Net cash from financing activities was positive Rs. 56.6 Cr in the half-year ended Sept-26, compared to negative Rs. 13.6 Cr in the prior comparable period (Page 14).

2 more points from MTAR Technologies Ltd's call on fundraising

Create a free account to keep reading this call

See what MTAR Technologies Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Order book as on 30th September 2026 stands at Rs. 5,976.5 Crores (Page 15).
Incoming orders for Q2FY27 totaled Rs. 1,207.2 Crores (Page 15).
The company has a diversified order book of Rs. 5,976.5 Crores as of 30th September 2026 (Page 15).

2 more points from MTAR Technologies Ltd's call on order book

Create a free account to keep reading this call

MTAR Technologies Ltd — Quarterly revenue & net profit

Revenue Net profit

Jun 2025Q1 FY26

Sep 2025Q2 FY26

Dec 2025Q3 FY26

Mar 2026Q4 FY26

Jun 2026Q1 FY27

Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹407 Cr, net profit ₹60 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What MTAR Technologies Ltd's management said in earlier quarters

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

MTAR Technologies Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were MTAR Technologies Ltd Q2 FY27 results?

Q2 FY27 Revenue from Operations: Rs. EBITDA for Q2 FY27: Rs.

What is MTAR Technologies Ltd share price analysis?

MTAR Technologies Ltd currently shows a neutral. The stock trades at a P/E of 160.4 with a market cap of ₹22,021 Cr. Investors should review the full earnings analysis for detailed insights.

Is MTAR Technologies Ltd planning capital expenditure?

Data Centre Infrastructure Solutions Facility - Leased manufacturing facility, infrastructure being established - First article orders to be executed within next 6 months (from Oct 2026) - Designed for significant ramp-up in production volumes (Page 24) - Greenfield Facility for Oil & Gas and Clean Energy (Fuel Cells Phase 2 Expansion) - To cater to Weatherford and others - Expected commissioning by end Nov 2026 (Page 23) - New Facility for Phase 3 Expansion of Clean Energy – Fuel Cells - Capacity augmentation expected by March 2027 - Focus on skilled manpower onboarding and automation for operational efficiency (Page 23) - Historical Capex Evidence - Increase in Property, Plant & Equipment from Rs.

Keep MTAR Technologies Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.